PerkinElmer Establishes $400M Loan Facility for Caliper Purchase | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PerkinElmer has entered into a commitment letter for a 364-day bridge loan facility for up to $400 million to fund its proposed purchase of Caliper Life Sciences, it disclosed this week in a document filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

The US House of Representatives science committee has passed a bill to require NSF to ensure it only funds projects that are in the national interest.

DuPont teams with genome editing firm Caribou Biosciences for agricultural applications of the technology.

A blogger reviews her experience learning about her gut microbiome by shipping a sample to uBiome.